New functionalities in Orphanet for orphan drugs, R&D and marketing authorisations to better serve the rare diseases community - Archive ouverte HAL Access content directly
Conference Papers Orphanet Journal of Rare Diseases Year : 2010

New functionalities in Orphanet for orphan drugs, R&D and marketing authorisations to better serve the rare diseases community

(1) , (1) , (1) , (1)
1

Abstract

n.a

Domains

Life Sciences [q-bio] Genetics
Fichier principal
Vignette du fichier
1750-1172-5-S1-P25.pdf (180.83 Ko) Télécharger le fichier
Vignette du fichier
1750-1172-5-S1-P25.xml (3.86 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Format : Other

Ed. BMC  : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-00668439

Submitted on : Thursday, February 9, 2012-5:13:00 PM

Last modification on : Friday, February 17, 2012-3:13:19 PM

Long-term archiving on: Thursday, May 10, 2012-2:58:13 AM

Download

Dates and versions

inserm-00668439 , version 1 (09-02-2012)

Identifiers

Cite

Virginie Hivert, Natalia Martin, Marc Hanauer, Ségolène Aymé. New functionalities in Orphanet for orphan drugs, R&D and marketing authorisations to better serve the rare diseases community. 5th European Conference on Rare Diseases (ECRD 2010), May 2010, Krakow, Poland. pp.P25, ⟨10.1186/1750-1172-5-S1-P25⟩. ⟨inserm-00668439⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM
208 View
324 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More